Does an intra-articular corticosteroid injection help relieve knee pain and swelling?

Intra-Articular Corticosteroid Injections for Knee Pain and Swelling

Yes, intra-articular corticosteroid injections effectively relieve knee pain and swelling in the short term (up to 4-6 weeks), particularly during acute flares, but the benefit is relatively short-lived and diminishes by 12-24 weeks. 1, 2

Evidence-Based Efficacy

The evidence consistently demonstrates that corticosteroid injections work, but with important temporal limitations:

• Short-term benefit (≤6 weeks): Multiple RCTs show significant pain relief with effect sizes ranging from 0.61 to 1.27 compared to placebo, with improvements in both pain and function at 1 and 4 weeks 1, 3
• Medium-term (6-24 weeks): Benefits persist but begin to wane, with no significant difference from placebo by 12-24 weeks 1, 4
• Long-term (≥24 weeks): No sustained benefit, with some evidence suggesting other interventions (hyaluronic acid, physiotherapy) may be superior 3

Optimal Clinical Indications

Corticosteroid injections are specifically indicated for acute flares of knee pain, especially when accompanied by joint effusion 1. The EULAR guidelines explicitly recommend this as their primary indication, though one crossover study suggested injections shouldn't be reserved exclusively for patients with effusion 1.

The 2022 AAOS guidelines found "considerable evidence" supporting corticosteroid use, with 19 high-quality and 6 moderate-quality studies, though noting the 3-month duration limitation 2.

Predictors of Response

Patients with less severe osteoarthritis (Kellgren-Lawrence grades 1-2) respond better than those with advanced disease 5. Specifically:

• Patients with KL grades 1-2 showed clinical improvement at all time points
• Obese patients with KL grades 3-4 had significantly worse outcomes 5
• Presence of effusion may predict better response, though evidence is mixed 1, 4
• Female gender associated with response at 3 weeks; previous injection history predicted non-response at 9 weeks 6

Critical Caveats

Accuracy of injection placement does not appear to affect outcomes - a pragmatic study using ultrasound verification found no difference in pain relief between accurate (70.5%) versus inaccurate intra-articular placement 6. This challenges the assumption that technical precision is paramount.

Safety considerations:

• Avoid injections within 3 months of planned joint replacement surgery (infection risk increases from 0.5% to 1.0%) 7
• Diabetic patients require glucose monitoring for 1-3 days post-injection due to transient hyperglycemia 7
• General consensus (though not evidence-based) suggests limiting to 3-4 injections per year in the same joint 7
• Avoid overuse of the injected joint for 24 hours, but immobilization is discouraged 7

Practical Algorithm

Use corticosteroid injections when:

1. Patient has acute knee pain flare with or without visible effusion
2. Short-term relief (4-6 weeks) is the goal
3. Patient has mild-to-moderate osteoarthritis (KL grades 1-2)
4. No joint replacement planned within 3 months
5. Patient is not obese with severe arthritis (lower likelihood of benefit)

Do not use as:

• A long-term pain management strategy
• Primary treatment in severe osteoarthritis (KL grades 3-4) with obesity
• Repeated intervention beyond 3-4 times per year

The evidence supports corticosteroids as an effective short-term intervention for acute symptom control, but clinicians must set appropriate expectations about the temporary nature of relief and consider alternative treatments for sustained benefit 1, 2, 3.